These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Current diagnostic techniques in genital herpes: their role in controlling the epidemic. Slomka MJ. Clin Lab; 2000; 46(11-12):591-607. PubMed ID: 11109508 [Abstract] [Full Text] [Related]
29. The burden of infection with herpes simplex virus type 1 and type 2: seroprevalence study in Estonia. Uusküla A, Nygard-Kibur M, Cowan FM, Mayaud P, French RS, Robinson JN, Brown DW. Scand J Infect Dis; 2004; 36(10):727-32. PubMed ID: 15513398 [Abstract] [Full Text] [Related]
30. Epidemiology of genital herpes simplex virus type 1 and 2 infections in southwestern Finland during a 10-year period (2003-2012). Kortekangas-Savolainen O, Orhanen E, Puodinketo T, Vuorinen T. Sex Transm Dis; 2014 Apr; 41(4):268-71. PubMed ID: 24622640 [Abstract] [Full Text] [Related]
31. Prevalence and risk factors for infection with herpes simplex virus type-1 and -2 among lesbians. Marrazzo JM, Stine K, Wald A. Sex Transm Dis; 2003 Dec; 30(12):890-5. PubMed ID: 14646636 [Abstract] [Full Text] [Related]
32. Genotypic analysis of sequential genital herpes simplex virus type 1 (HSV-1) isolates of patients with recurrent HSV-1 associated genital herpes. Roest RW, Carman WF, Maertzdorf J, Scoular A, Harvey J, Kant M, Van Der Meijden WI, Verjans GM, Osterhaus AD. J Med Virol; 2004 Aug; 73(4):601-4. PubMed ID: 15221906 [Abstract] [Full Text] [Related]
33. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. Stanberry LR, Spruance SL, Cunningham AL, Bernstein DI, Mindel A, Sacks S, Tyring S, Aoki FY, Slaoui M, Denis M, Vandepapeliere P, Dubin G, GlaxoSmithKline Herpes Vaccine Efficacy Study Group. N Engl J Med; 2002 Nov 21; 347(21):1652-61. PubMed ID: 12444179 [Abstract] [Full Text] [Related]
35. Epidemiology of genital herpes simplex virus infection in developed countries. Malkin JE. Herpes; 2004 Apr 21; 11 Suppl 1():2A-23A. PubMed ID: 15115626 [Abstract] [Full Text] [Related]
36. Increasing role of herpes simplex virus type 1 in first-episode anogenital herpes in heterosexual women and younger men who have sex with men, 1992-2006. Ryder N, Jin F, McNulty AM, Grulich AE, Donovan B. Sex Transm Infect; 2009 Oct 21; 85(6):416-9. PubMed ID: 19273479 [Abstract] [Full Text] [Related]
37. Unexpected high prevalence of herpes simplex virus (HSV) type 2 seropositivity and HSV genital shedding in pregnant women living in an East Paris suburban area. LeGoff J, Saussereau E, Boulanger MC, Chemin C, Si-Mohamed A, Bélec L, Maisonneuve L. Int J STD AIDS; 2007 Sep 21; 18(9):593-5. PubMed ID: 17785000 [Abstract] [Full Text] [Related]
38. Proportion of herpes simplex virus (HSV) type 1 and type 2 among genital and extragenital HSV isolates. Löwhagen GB, Tunbäck P, Bergström T. Acta Derm Venereol; 2002 Sep 21; 82(2):118-20. PubMed ID: 12125939 [Abstract] [Full Text] [Related]
39. Trends in herpes simplex virus type 1 and 2 infections among patients diagnosed with genital herpes in a Finnish sexually transmitted disease clinic, 1994-2002. Kortekangas-Savolainen O, Vuorinen T. Sex Transm Dis; 2007 Jan 21; 34(1):37-40. PubMed ID: 17195754 [Abstract] [Full Text] [Related]
40. Herpes simplex virus type 2 seropositivity in a sexually transmitted disease clinic in Israel. Feldman PA, Steinberg J, Madeb R, Bar G, Nativ O, Tal J, Srugo I. Isr Med Assoc J; 2003 Sep 21; 5(9):626-8. PubMed ID: 14509150 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]